Description
BUPRENORPHINE TEST CARDS
First action · last action
2014-10-16 · 2014-10-16
Transactions
1
First transaction's obligation
$2,881
Base + all options value (sum of deltas)
$14,491
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
SMALL BUSINESS SET ASIDE - TOTAL
Offers received
2
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-10-16+$2,881= $2,881
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-10-16 | +$2,881 | $2,881 | BUPRENORPHINE TEST CARDS |
Related awards · 5
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other recipients under 6550 from 693-WILKES-BARRE (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24415F0177 | CARDINAL HEALTH 200, LLC | 693-WILKES-BARRE | $22,521 | FY2015 |
| VA24414J3281 | ROCHE DIAGNOSTICS CORPORATION | 693-WILKES-BARRE | $52,446 | FY2014 |
| VA24414J3066 | CEPHEID | 693-WILKES-BARRE | $191,032 | FY2014 |
| VA24414J2383 | ABBOTT RAPID DX NORTH AMERICA LLC | 693-WILKES-BARRE | $168,925 | FY2014 |
| VA69312P0127 | REMEL INC. | 693-WILKES-BARRE | $5,495 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24415F0134_3600_-NONE-_-NONE- · retrieved 2026-09-26.